The albumin-bilirubin grade improves hepatic reserve estimation post-sorafenib failure: implications for drug development-Reference-Cited by-同舟云学术

The albumin-bilirubin grade improves hepatic reserve estimation post-sorafenib failure: implications for drug development

Author:

Pinato D. J.¹,Yen C.¹,Bettinger D.²,Ramaswami R.¹,Arizumi T.³,Ward C.¹,Pirisi M.⁴⁵,Burlone M. E.⁴,Thimme R.²,Kudo M.³,Sharma R.¹

Affiliation:

1. Department of Surgery & Cancer; Hammersmith Campus of Imperial College London; London UK

2. Department of Medicine II; University Hospital Freiburg; Freiburg Germany

3. Department of Gastroenterology and Hepatology; Kindai University School of Medicine; Osaka Japan

4. Department of Translational Medicine; Università degli Studi del Piemonte Orientale “A. Avogadro”; Novara Italy

5. Interdisciplinary Research Center of Autoimmune Diseases; Università degli Studi del Piemonte Orientale “A. Avogadro”; Novara Italy

Funder

Academy of Medical Sciences

National Institute for Health Research

Albert-Ludwigs-Universität Freiburg

Wellcome Trust

Medical Research Council

British Heart Foundation

Arthritis Research UK

Royal College of Physicians

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

Reference36 articles.

4. Comparative dosing and efficacy of sorafenib in hepatocellular cancer patients with varying liver dysfunction;Al-Rajabi;J Gastrointest Oncol,2015

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献